WEBINAR - March 7, 2024 at 1pm ET – Rethinking therapeutic response assessment in clinical trials using ultra-sensitive ctDNA – new data and promising applications

Register now

News & Publications

PhaseEd-Seq MRD Detection May Provide Effective Alternative to Standard Imaging in LBCL


Back to all